Table 2.
FMT outcomes.
| CDI recurrence within 90 days after FMT, n (%) | Days until CDI recurrence, median (range) | |
|---|---|---|
| All subjects | ||
| Normal zinc (n = 49) | 3 (6.12) | 72 (6–88) |
| Low zinc (n = 31) | 5 (16.13) | 15 (4–81) |
| Total (n = 80) | 8 (10.00) | 28 (4–88) |
| p value | 0.097 | 0.456 |
| Test utilized | Wilcoxon test | Mann–Whitney U |
| Low zinc subjects | ||
| Not supplemented (n = 6) | 3 (50.00) | 14 (4–81) |
| Supplemented (n = 25) | 2 (8.00) | 28 (15–41) |
| Total (n = 31) | 5 (16.13) | 15 (4–81) |
| p value | 0.014 | 0.564 |
| Test utilized | Wilcoxon test | Mann–Whitney U |
CDI, Clostridium difficile infection.